Description | This product is a human neutralizing antibody clone 38-3-11A binding EV71 capsid. It neutralized virus at picomolar level and fully protected mice from a lethal EV71 infection at a prophylactic dose of 0.4 mg/kg. In pre- and post-attachment neutralization assays, neutralizing antibodies 38-3-11A has potent inhibitory activity. |
Clonality | Monoclonal |
Host Species | Human |
Target Species | EV71 |
Epitope | 38-3-11A recognizes a threefold proximal epitope composed of VP2 BC and HI loops from one protomer and VP3 BC and HI loops of another protomer from a neighbouring pentamer. |
EC50 | 0.117 μg/mL |
Isotype | Human IgG |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein A purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA; FC; IP; WB; Neut |
Application Notes | The antibody was detected by ELISA, Flow cytometry (FC) and Neutralization assay. ELISA: The antibody-containing cell culture supernatants or purified antibody was applied and bound virus_x0002_specific antibody was detected with HRP-conjugated rabbit anti-human IgG secondary antibody. Flow cytometry (FC): 5 μg/mL Neutralization assay (Neut): Serially diluted antibody in virus dilution medium was incubated with 100 TCID50 of virus preparation at 37°C for 2 h. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | EV71 VP |
Alternative Name | Enterovirus 71 capsid protein |
Research Area | Infectious Disease |
Related Disease | Meningitis, Encephalitis and Acute flaccid myelitis |